Why AngioDynamics Stock Popped, Then Dropped Today

AngioDynamics reported Q4 2025 sales of $80.2 million and a smaller-than-expected adjusted loss of $0.03 per share, yet its stock declined nearly 10%. The negative market reaction was driven by a 160 basis point decline in gross profit margins, persistent GAAP losses ($0.15/share in Q4, $0.83/share for FY2025), and a wider-than-anticipated FY2026 adjusted loss forecast of $0.25-$0.35 per share, exceeding analyst expectations. The absence of GAAP loss guidance for the upcoming fiscal year further heightened investor concerns regarding the company's long-term profitability despite revenue growth.

Analysis

AngioDynamics (ANGO) presented a mixed financial picture for Q4 2025, where a top-line beat was significantly undermined by deteriorating profitability and a weak forward outlook, culminating in a nearly 10% stock price decline. The company reported quarterly revenue of $80.2 million, a 13% year-over-year increase, and a narrower-than-expected adjusted loss of $0.03 per share versus a consensus forecast of a $0.12 loss. However, these positive headline figures were overshadowed by a 160 basis point contraction in gross profit margins to 52.7% and a persistent GAAP loss of $0.15 per share for the quarter ($0.83 for the full fiscal year 2025). Investor sentiment was further eroded by the company's fiscal 2026 guidance; while the revenue forecast of $305-$310 million is ahead of Street estimates, the projected adjusted loss of $0.25 to $0.35 per share is materially worse than the anticipated $0.23 loss. The lack of a GAAP loss forecast for the upcoming year compounds uncertainty, signaling that a return to profitability is not an immediate prospect despite continued revenue growth.

Key Decisions for Investors

• Investors should prioritize the company's weak profitability and margin erosion over its top-line revenue growth, as the market is clearly punishing the stock for its inability to convert sales into profit.
• The fiscal 2026 guidance for a wider-than-expected adjusted loss, coupled with the absence of a GAAP forecast, represents a significant red flag that suggests continued fundamental headwinds and warrants a cautious or defensive stance.
• Consider avoiding or reducing positions until management provides a clear and credible path to GAAP profitability and demonstrates a stabilization or improvement in gross margins.
• The sharp negative stock reaction to the earnings release indicates that the market has little tolerance for the current cash burn, suggesting further downside risk if future quarters do not show material improvement.